Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01384916 · ClinicalTrials.gov registry record · Phase 2
Holistic Approaches to Depression
A Phase 2 study of Depression, sponsored by Butler Hospital.
- Completed
- Registry status
- Phase 2
- Development phase
- 121
- Enrollment target
- 1
- Study location
NCT01384916: Completed Phase 2 study of Depression, sponsored by Butler Hospital.
NCT01384916 is a Phase 2 study of Depression that has completed, run by Butler Hospital. The registered enrollment target is 121 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01384916, a Phase 2 study of Depression, has completed, sponsored by Butler Hospital.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 121 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to investigate whether yoga or a health education group alleviate depressive symptoms for an individual with a partial response to antidepressant medication.
Primary Outcome
Depression
Conditions Studied
Interventions
- BEHAVIORAL Yoga
- BEHAVIORAL Healthy Living Workshop
Study Locations (1)
Rhode Island
- Butler Hospital - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 121 participants |
| Start Date | 2011-06 |
| Est. Completion | 2015-03 |
| Phase | Phase 2 |
What the finished NCT01384916 record still lists
NCT01384916 is an interventional study that assigns participants to a tested intervention. The registered 121 participants enrollment target is mid-sized for trials with a published cap, below the 786-participant average among 679 other Depression trials with a reported enrollment target (85% lower).
The record links to 1 condition, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Yoga is the first listed.
NCT01384916 reports a single indexed study location in Rhode Island.
Frequently Asked Questions
What is clinical trial NCT01384916 about?
NCT01384916 is a clinical study titled "Holistic Approaches to Depression". The purpose of the study is to investigate whether yoga or a health education group alleviate depressive symptoms for an individual with a partial response to antidepressant medication.
What is the current status of trial NCT01384916?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 121 participants. The study started on 2011-06. Estimated completion is 2015-03.
What conditions does trial NCT01384916 study?
This clinical trial studies the following conditions: Depression.
What interventions are being tested in trial NCT01384916?
The interventions under investigation include: Yoga (BEHAVIORAL), Healthy Living Workshop (BEHAVIORAL).
Who is sponsoring clinical trial NCT01384916?
This trial is sponsored by Butler Hospital, which has 103 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01384916 being conducted?
This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01384916's enrollment target sits among peer trials
121 291st of 679 higher than 389 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Sleep to Reduce Incident Depression Effectively in Peripartum
RECRUITING · Phase 2
-
Resources, Inspiration, Support and Empowerment (RISE) for Black Pregnant Women
RECRUITING · Phase 2
-
TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors
RECRUITING · Phase 2
-
Cannabidiol and Older Adult Cannabis Users
RECRUITING · Phase 2
-
Evaluation of a Keto-Like Supplement on Brain Responses to Emotional Stimuli in Depression
RECRUITING · Phase 2
-
Neurobiology of Suicide
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03476681 · 121 participants · Phase 1
Study of NEO-201 in Solid Tumors Expansion Cohorts
- NCT04655118 · 121 participants · Phase 2
Study of TL-895 in Subjects With Myelofibrosis or Indolent Systemic Mastocytosis
- NCT04676802 · 121 participants · Phase 2
Pain Relief After Trapeziectomy: Ibuprofen & Acetaminophen Versus Oxycodone
- NCT05169515 · 121 participants · Phase 1
A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab or Glofitamab in Combination With CC-220 and/or CC-99282 in Participants With B-Cell Non-Hodgkin Lymphoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia